Records containing: Renal Cell Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-01-07Risk of Pancreatic Cancer and Renal Cancer in Patients Exposed to Gabapentin in the United Kingdom General Practice Research Database
-
CLINICAL_TRIALS study record update · 2010-12-15Phase I/II Trial Evaluating Toxicity and Efficacy of Adding Stereotactic Body Radiotherapy to Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer
-
CLINICAL_TRIALS study record update · 2010-12-07ClinicalTrials.gov study NCT01254838
-
CLINICAL_TRIALS study record update · 2010-11-15A Phase I/II Evaluation of Cytokine Induced Killer Cells Stimulated by DC(DCIK) Immunotherapy in Patients With Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2010-11-04A Non-Interventional Study With SUTENT® In The First Line Treatment Of Renal Cell Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2010-08-24Granulocyte-macrophage Colony-stimulating Factor, Interferon Alpha and Interleukin-2 as Adjuvant Treatment for High-risk Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2010-05-10Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors
-
CLINICAL_TRIALS study record update · 2010-04-09T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY)
-
CLINICAL_TRIALS study record update · 2010-03-18Study to the Humoral and Cellular Immunoresponse After Influenza Vaccination in Patients With Metastasized RCC or GIST Treated With a Tyrosine Kinase Inhibitor(Sunitinib or Sorafenib)
-
CLINICAL_TRIALS study record update · 2010-03-16An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037
-
CLINICAL_TRIALS study record update · 2010-02-26A Phase I Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma Patients
-
CLINICAL_TRIALS study record update · 2010-02-19A Phase 2 Study of XL999 Administered Intravenously to Subjects With Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2010-01-06A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Locally Advanced Renal-Cell Carcinoma After Radical Nephrectomy
-
CLINICAL_TRIALS study record update · 2009-12-23Effects of Physical Activity on the Endothelial and Cardiac Function of Patients With Renal Cell Carcinoma Receiving a Thyrosine Kinase Inhibitor (Sunitinib)
-
CLINICAL_TRIALS study record update · 2009-04-10A Multicenter, Phase II, Randomized, Blinded, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Sutent With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer
-
CLINICAL_TRIALS study record update · 2009-02-26A Randomized Open Label Multicenter Phase II Study of First Line Therapy With Sorafenib in Association With IL-2 vs Sorafenib Alone in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2007-12-28A Phase I/II Study of Temsirolimus and Sunitinib in Subjects With Advanced Renal Cell Carcinoma